Showing results (1221-1230 of 1,341) with videos related to
Sort By:
Pageof 135
European Heart Journal. Cardiovascular Pharmacotherapy|January 25, 2024
Effects of albiglutide on myocardial infarction and ischaemic heart disease outcomes in patients with type 2 diabetes and cardiovascular disease in the Harmony Outcomes trialKonstantin A Krychtiuk, Guillaume Marquis-Gravel, Shannon Murphy, et al.Journal of Spinal Disorders|June 29, 2000
A critical appraisal of the reporting of the National Acute Spinal Cord Injury Studies (II and III) of methylprednisolone in acute spinal cord injuryW P Coleman, D Benzel, D W Cahill, et al.Diabetes, Obesity & Metabolism|March 25, 2018
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Shelby D Reed, Yanhong Li, Jose Leal, et al.Best Practice & Research. Clinical Anaesthesiology|December 4, 2019
Newer nerve blocks in pediatric surgeryAlan D Kaye, Jeremy B Green, Kelly S Davidson, et al.Journal of the National Cancer Institute|June 2, 2005
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrenceDavid S Alberts, María Elena Martínez, Lisa M Hess, et al.Journal of the American Board of Family Medicine : JABFM|June 27, 2025
Blood Pressure Medication Side Effect Symptoms and Patient Treatment Satisfaction and AdherenceKaren L Margolis, A Lauren Crain, Pamala A Pawloski, et al.JACC. Heart Failure|December 13, 2021
Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and DiabetesMuhammad Shahzeb Khan, Nicole Solomon, Adam D DeVore, et al.Lancet (London, England)|October 7, 2018
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trialAdrian F Hernandez, Jennifer B Green, Salim Janmohamed, et al.Diabetes, Obesity & Metabolism|June 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE TrialJanet B McGill, Jennifer B Green, Hiddo J L Heerspink, et al.Diabetes Care|September 16, 2016
Pancreatic Safety of Sitagliptin in the TECOS StudyJohn B Buse, M Angelyn Bethel, Jennifer B Green, et al.Pageof 135